B+
Bull case
25%
Probability
Target price
$89.70
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
ASH
AshlandBNYSE / Materials
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
50%
Probability
Target price
$80.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$68.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-08-08
Recent news sentiment (30D)
+24.3
Positive
Company
-
Unavailable
Macro
+24.3
Positive
Pulse
-
Unavailable
Weekly research (10D)
-24.0
Negative
Sentiment proxy
+76.6
Score
AI commentary
News tone is mixed-positive after strong sales and reaffirmed guidance, offset by lower Adjusted EBITDA and execution concerns. Post-print price reaction, options data, short interest, employee sentiment, and analyst revisions are unavailable or not supported in the packet; confidence therefore remains moderate.
RankAlpha Sentiment Codex - 2026-08-08
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-07-28eventQ3 FY2026 results reaffirmed full-year outlookMedium impact
Q3 sales rose 7% year over year and volumes rose 6%, while Ashland reaffirmed FY2026 sales guidance of $1.835-$1.870 billion and Adjusted EBITDA guidance of $385-$400 million. Adjusted EBITDA declined 4%, so the read-through is constructive but mixed [#SEC-8K-2026-07-28].
2026-09-30catalystHopewell execution and plant reliabilityMedium impact
Management reported sequential profitability improvement and continued operational work, including improving reliability and throughput across the network. Hopewell productivity remains the clearest near-term execution swing factor [#SEC-8K-2026-07-28].
2026-12-31catalystLife Sciences, Personal Care and coatings growthHigh impact
Management cited double-digit Life Sciences gains, continued Personal Care momentum, and coatings share gains. Sustained demand plus better manufacturing execution could support gradual margin recovery, but the outcome remains conditional [#SEC-8K-2026-07-28].
Recommendation
N/A
No formal recommendation provided.
As of 2026-08-08 • Updated nightlySource: Internal modelMethodology